NDC 50090-5834

Cabergoline

Cabergoline

Cabergoline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Cabergoline.

Product ID50090-5834_98313eca-ab65-4a40-b7d1-a05ab33a2b33
NDC50090-5834
Product TypeHuman Prescription Drug
Proprietary NameCabergoline
Generic NameCabergoline
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-08-09
Marketing CategoryANDA /
Application NumberANDA204735
Labeler NameA-S Medication Solutions
Substance NameCABERGOLINE
Active Ingredient Strength1 mg/1
Pharm ClassesErgolines [CS],Ergot Derivative [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-5834-0

8 TABLET in 1 BOTTLE (50090-5834-0)
Marketing Start Date2021-10-27
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cabergoline" or generic name "Cabergoline"

NDCBrand NameGeneric Name
0093-5420CabergolineCabergoline
23155-823CabergolineCabergoline
49884-673CabergolineCabergoline
50090-3157CabergolineCabergoline
50090-3951CabergolineCabergoline
50090-5834CabergolineCabergoline
50742-118CabergolineCabergoline
59762-1005Cabergolinecabergoline
68071-4596CabergolineCabergoline
70518-2379CabergolineCabergoline

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.